Castle Hook Partners’s Twist Bioscience TWST Stock Holding History

Castle Hook Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	+10,681	New	+$695K	0.01%	70

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Castle Hook Partners's TWST Position: Q2 2026 in Review

Castle Hook Partners opened a new position in Twist Bioscience (TWST) in Q2 2026: 10,681 shares worth $1.1M. The stake represents 0.01% of the portfolio and ranks #70 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Castle Hook Partners held 10,681 shares of Twist Bioscience worth $1.1M as of Q2 2026.
Twist Bioscience was a new Castle Hook Partners position in Q2 2026.
Twist Bioscience made up 0.01% of Castle Hook Partners's portfolio in Q2 2026, its #70 holding.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Castle Hook Partners's 13F filing for Q2 2026, filed 14 Aug 2026.